These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2201665)

  • 1. Characteristics of antineuronal antibodies in systemic lupus erythematosus patients with and without central nervous system involvement: the role of mycobacterial cross-reacting antigens.
    Avinoach I; Amital-Teplizki H; Kuperman O; Isenberg DA; Shoenfeld Y
    Isr J Med Sci; 1990 Jul; 26(7):367-73. PubMed ID: 2201665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low serum antimycobacterial glycolipid antibody titers in the sera of patients with systemic lupus erythematosus associated with central nervous system involvement.
    Teplizki H; Buskila D; Argov S; Isenberg D; Coates AR; Sukenik S; Horowitz J; Shoenfeld Y
    J Rheumatol; 1987 Jun; 14(3):507-11. PubMed ID: 3114486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antineuronal antibodies and neuropsychiatric systemic lupus erythematosus].
    Chen WZ; Zhang NZ; Jiang M
    Zhonghua Nei Ke Za Zhi; 1990 Mar; 29(3):161-4, 190. PubMed ID: 2209246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-ELISA detection of antineuronal antibodies in central nervous system involvement in systemic lupus erythematosus.
    Zhang X; Shu H; Zhang F; Tian X; Dong Y
    Ann Rheum Dis; 2007 Apr; 66(4):530-2. PubMed ID: 16905576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibody to a novel neuronal antigen in systemic lupus erythematosus and in normal human sera.
    Toh Bh; Mackay IR
    Clin Exp Immunol; 1981 Jun; 44(3):555-9. PubMed ID: 7035032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihistone antibodies in systemic lupus erythematosus.
    Rubin RL; Waga S
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():118-26. PubMed ID: 2441043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus.
    Isshi K; Hirohata S
    Arthritis Rheum; 1998 Oct; 41(10):1819-27. PubMed ID: 9778223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to neuroblastoma cell surface antigens in neuropsychiatric lupus.
    Danon YL; Garty BZ
    Neuropediatrics; 1986 Feb; 17(1):23-7. PubMed ID: 3960280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J; Kumar S; Isenberg DA
    Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus.
    Hoffman IE; Lauwerys BR; De Keyser F; Huizinga TW; Isenberg D; Cebecauer L; Dehoorne J; Joos R; Hendrickx G; Houssiau F; Elewaut D
    Ann Rheum Dis; 2009 Mar; 68(3):412-5. PubMed ID: 18930995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
    Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
    Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A subset of antibodies from the sera of patients with systemic lupus erythematosus react with vimentin and DNA.
    Sánchez A; Ossorio C; Alvaro-Gracia JM; Padilla R; Avila J
    J Rheumatol; 1990 Feb; 17(2):205-9. PubMed ID: 1690805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An antineuronal antibody cross-reacting with erythrocytes and lymphocytes in systemic lupus erythematosus.
    Bresnihan B; Oliver M; Williams B; Hughes GR
    Arthritis Rheum; 1979 Apr; 22(4):313-20. PubMed ID: 371627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to histones in systemic lupus erythematosus.
    Fishbein E; Alarcon-Segovia D; Vega JM
    Clin Exp Immunol; 1979 Apr; 36(1):145-50. PubMed ID: 380854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies that bind glomeruli: cross-reactivity with bacterial antigen.
    Chowdhry IA; Kowal C; Hardin J; Zhou Z; Diamond B
    Arthritis Rheum; 2005 Aug; 52(8):2403-10. PubMed ID: 16052539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of two associated precipitating autoantibodies (DA1 and DA2) in sera from patients with systemic lupus erythematosus.
    Asero R; Origgi L; Bertetti E; D'Agostino P; Riboldi P
    J Clin Lab Immunol; 1988 Jun; 26(2):63-6. PubMed ID: 3264026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
    Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus.
    Husebye ES; Sthoeger ZM; Dayan M; Zinger H; Elbirt D; Levite M; Mozes E
    Ann Rheum Dis; 2005 Aug; 64(8):1210-3. PubMed ID: 15708887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
    Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenetic role of anti-vascular endothelial cell antibodies in systemic lupus erythematosus.
    Zhou SF; Wang XM; Zhong HP; Li A; Wang MX; Wang SL; Zhang L; Du XH
    Chin Med J (Engl); 1989 Jul; 102(7):505-9. PubMed ID: 2517066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.